Literature DB >> 15618202

Shiga-toxigenic Escherichia coli-inoculated neonatal piglets develop kidney lesions that are comparable to those in humans with hemolytic-uremic syndrome.

J F Pohlenz1, K R Winter, E A Dean-Nystrom.   

Abstract

Kidney lesions similar to those in humans with hemolytic-uremic syndrome were observed histologically in 82 of 122 piglets inoculated intragastrically with Shiga-toxigenic Escherichia coli but not in 29 controls. The locations of lesions matched locations where Stx-2 binding and Gb3 (globotriasylceramide receptors for Stx) were identified immunohistochemically.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15618202      PMCID: PMC538958          DOI: 10.1128/IAI.73.1.612-616.2005

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  31 in total

1.  Hemolytic uremic syndrome: epidemiology, pathophysiology, and therapy.

Authors:  Sharon P Andreoli; Howard Trachtman; David W K Acheson; Richard L Siegler; Tom G Obrig
Journal:  Pediatr Nephrol       Date:  2002-04       Impact factor: 3.714

2.  Detection and characterization of Shiga toxin-producing Escherichia coli in feral pigeons.

Authors:  S Morabito; G Dell'Omo; U Agrimi; H Schmidt; H Karch; T Cheasty; A Caprioli
Journal:  Vet Microbiol       Date:  2001-09-28       Impact factor: 3.293

Review 3.  Pathogenesis of Shiga toxin-associated hemolytic uremic syndrome.

Authors:  F Proulx; E G Seidman; D Karpman
Journal:  Pediatr Res       Date:  2001-08       Impact factor: 3.756

4.  Cloning and sequencing of a Shiga-like toxin type II variant from Escherichia coli strain responsible for edema disease of swine.

Authors:  D L Weinstein; M P Jackson; J E Samuel; R K Holmes; A D O'Brien
Journal:  J Bacteriol       Date:  1988-09       Impact factor: 3.490

5.  A clinicopathological study of 24 children with hemolytic uremic syndrome. A report of the Southwest Pediatric Nephrology Study Group.

Authors:  J C Argyle; R J Hogg; T J Pysher; F G Silva; R L Siegler
Journal:  Pediatr Nephrol       Date:  1990-01       Impact factor: 3.714

6.  Shiga toxin binding to isolated porcine tissues and peripheral blood leukocytes.

Authors:  Kellie R K Winter; William C Stoffregen; Evelyn A Dean-Nystrom
Journal:  Infect Immun       Date:  2004-11       Impact factor: 3.441

7.  Ferrets as a model system for renal disease secondary to intestinal infection with Escherichia coli O157:H7 and other Shiga toxin-producing E. coli.

Authors:  Jon B Woods; Clare K Schmitt; Stephen C Darnell; Karen C Meysick; Alison D O'Brien
Journal:  J Infect Dis       Date:  2002-01-22       Impact factor: 5.226

8.  Vaccination of pregnant dams with intimin(O157) protects suckling piglets from Escherichia coli O157:H7 infection.

Authors:  Evelyn A Dean-Nystrom; Lisa J Gansheroff; Melody Mills; Harley W Moon; Alison D O'Brien
Journal:  Infect Immun       Date:  2002-05       Impact factor: 3.441

9.  Tumour necrosis factor alpha is not an essential component of verotoxin 1-induced toxicity in mice.

Authors:  Vince M Wolski; Anna M Soltyk; James L Brunton
Journal:  Microb Pathog       Date:  2002-06       Impact factor: 3.738

10.  One of two copies of the gene for the activatable shiga toxin type 2d in Escherichia coli O91:H21 strain B2F1 is associated with an inducible bacteriophage.

Authors:  Louise D Teel; Angela R Melton-Celsa; Clare K Schmitt; Alison D O'Brien
Journal:  Infect Immun       Date:  2002-08       Impact factor: 3.441

View more
  10 in total

1.  Shiga toxin subtypes display dramatic differences in potency.

Authors:  Cynthia A Fuller; Christine A Pellino; Michael J Flagler; Jane E Strasser; Alison A Weiss
Journal:  Infect Immun       Date:  2011-01-03       Impact factor: 3.441

2.  Differential virulence of clinical and bovine-biased enterohemorrhagic Escherichia coli O157:H7 genotypes in piglet and Dutch belted rabbit models.

Authors:  Smriti Shringi; Alexis García; Kevin K Lahmers; Kathleen A Potter; Sureshkumar Muthupalani; Alton G Swennes; Carolyn J Hovde; Douglas R Call; James G Fox; Thomas E Besser
Journal:  Infect Immun       Date:  2011-10-24       Impact factor: 3.441

3.  Differences in virulence among Escherichia coli O157:H7 strains isolated from humans during disease outbreaks and from healthy cattle.

Authors:  Diane R Baker; Rodney A Moxley; Mike B Steele; Jeffrey T Lejeune; Jane Christopher-Hennings; Ding-Geng Chen; Philip R Hardwidge; David H Francis
Journal:  Appl Environ Microbiol       Date:  2007-09-21       Impact factor: 4.792

4.  Development of an experimental hemolytic uremic syndrome in rats.

Authors:  Elsa Zotta; Nestor Lago; Federico Ochoa; Horacio A Repetto; Cristina Ibarra
Journal:  Pediatr Nephrol       Date:  2008-02-06       Impact factor: 3.714

5.  Escherichia coli Shiga Toxin Mechanisms of Action in Renal Disease.

Authors:  Tom G Obrig
Journal:  Toxins (Basel)       Date:  2010-12-02       Impact factor: 4.546

6.  A Topographical Atlas of Shiga Toxin 2e Receptor Distribution in the Tissues of Weaned Piglets.

Authors:  Daniel Steil; Robert Bonse; Iris Meisen; Gottfried Pohlentz; German Vallejo; Helge Karch; Johannes Müthing
Journal:  Toxins (Basel)       Date:  2016-11-30       Impact factor: 4.546

7.  Comparison of clinical and immunological findings in gnotobiotic piglets infected with Escherichia coli O104:H4 outbreak strain and EHEC O157:H7.

Authors:  Bettina Wöchtl; Florian Gunzer; Wilhelm Gerner; Hagen Gasse; Michaela Koch; Zoltán Bagó; Martin Ganter; Herbert Weissenböck; Nora Dinhopl; Sina M Coldewey; Alexandra von Altrock; Karl-Heinz Waldmann; Armin Saalmüller; Kurt Zimmermann; Jörg Steinmann; Jan Kehrmann; Ludger Klein-Hitpass; Jochen Blom; Ralf Ehricht; Ines Engelmann; Isabel Hennig-Pauka
Journal:  Gut Pathog       Date:  2017-05-25       Impact factor: 4.181

8.  Efficacy of Urtoxazumab (TMA-15 Humanized Monoclonal Antibody Specific for Shiga Toxin 2) Against Post-Diarrheal Neurological Sequelae Caused by Escherichia coli O157:H7 Infection in the Neonatal Gnotobiotic Piglet Model.

Authors:  Rodney A Moxley; David H Francis; Mizuho Tamura; David B Marx; Kristina Santiago-Mateo; Mojun Zhao
Journal:  Toxins (Basel)       Date:  2017-01-26       Impact factor: 4.546

9.  Structural Insights into Escherichia coli Shiga Toxin (Stx) Glycosphingolipid Receptors of Porcine Renal Epithelial Cells and Inhibition of Stx-Mediated Cellular Injury Using Neoglycolipid-Spiked Glycovesicles.

Authors:  Johanna Detzner; Caroline Gloerfeld; Gottfried Pohlentz; Nadine Legros; Hans-Ulrich Humpf; Alexander Mellmann; Helge Karch; Johannes Müthing
Journal:  Microorganisms       Date:  2019-11-19

Review 10.  The Role of Escherichia coli Shiga Toxins in STEC Colonization of Cattle.

Authors:  Christian Menge
Journal:  Toxins (Basel)       Date:  2020-09-21       Impact factor: 4.546

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.